After analysis, we found that there are 4 metabolic pathways that are closely related to the treatment of depression, namely ABC transporters, biosynthetic of amino acids, neuroactive ligand-receptor interaction, and synaptic vesicle cycle. The gene discussed is ABCG2; the disease is depressive symptom measurement.